Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Black Diamond Therapeutics, Inc. Common Stock (BDTX)

Biological Products, (no Disgnostic Substances)

https://www.blackdiamondtherapeutics.com

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-189 and BDTX-1535.

ONE MAIN STREET, 14TH FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/30/2020

Market Cap

292,695,382

Shares Outstanding

51,640,000

Weighted SO

51,635,184

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

PASG --.--%

TCRR --.--%

HARP --.--%

ALEC --.--%

RVMD --.--%

BCEL --.--%

STOK --.--%

FIXX --.--%

Beta

2.4950

Last Div

0.0000

Range

1.62-7.66

Chg

0.2000

Avg Vol

645500

Mkt Cap

292695382

Exch

NASDAQ

Country

US

Phone

617 252 0848

DCF Diff

4.4665

DCF

0.7035

Div Yield

0.0000

P/S

59.8070

EV Multiple

-3.2611

P/FV

2.5734

Div Yield %

0.0000

P/E

-3.5470

PEG

-0.1837

Payout

0.0000

Current Ratio

6.8742

Quick Ratio

6.8742

Cash Ratio

1.7794

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

257.6272

CCC

-257.6272

Gross Margin

0.7791

Op Margin

-17.8265

Pretax Margin

-16.4587

Net Margin

-16.4587

Eff Tax Rate

-0.0157

ROA

-0.5370

ROE

-0.6908

ROCE

-0.6632

NI/EBT

1.0000

EBT/EBIT

0.9233

EBIT/Rev

-17.8265

Debt Ratio

0.1586

D/E

0.2142

LT Debt/Cap

0.1560

Total Debt/Cap

0.1764

Int Coverage

-127.1764

CF/Debt

-2.8695

Equity Multi

1.3510

Rec Turnover

0.0000

Pay Turnover

1.4168

Inv Turnover

0.0000

FA Turnover

0.2217

Asset Turnover

0.0326

OCF/Share

-1.2373

FCF/Share

-1.2373

Cash/Share

2.2295

OCF/Sales

-13.9442

FCF/OCF

1.0000

CF Coverage

-2.8695

ST Coverage

-20.9592

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.5734

P/B

2.5734

P/S

59.8070

P/E

-3.5470

P/FCF

-4.2890

P/OCF

-4.1866

P/CF

-4.1866

PEG

-0.1837

P/S

59.8070

EV Multiple

-3.2611

P/FV

2.5734

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 06, 07:45 Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Revenue Product Segmentation